By Joyce Yu, PharmD, ORISE Fellow; and Clydette Powell, MD, MPH, FAAP, Director, Division of Health Care Quality, ODPHP

On October 31, 2018, the National Clinical Care Commission held its inaugural meeting in person at the National Institutes of Health (NIH) in Bethesda, MD. The Commission, a newly established federal advisory committee, is charged to evaluate and make recommendations regarding programs of the U.S.…

On November 1, 2017, ODPHP held a free public listening session titled Partnering to Prevent Hypoglycemia in Washington, DC. Participants included federal partners, public and private health professionals, organizations, and consumer representatives.

Keynote speakers included:

Don Wright, MD, MPH, Deputy Assistant Secretary for Health and Director of ODPHP, U.S. Department of Health and Human Services LaShawn McIver, MD, MPH, Senior Vice President of Government Affairs and Advocacy, American Diabetes Association

The listening session focused on hypoglycemia as an important public health issue and federal efforts to reduce hypoglycemic adverse drug events (ADEs).…

ODPHP recently established the National Clinical Care Commission to consider complex metabolic or autoimmune diseases that result from insulin-related issues and represent a significant disease burden in the United States. The Commission will consist of both federal and non-federal members who will provide recommendations to the Secretary and Congress on coordination and leveraging of federal programs related to these issues.…